Tompkins Financial’s Chemed CHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-174
| Closed | -$77.9K | – | 643 |
|
|
2025
Q3 | $77.9K | Hold |
174
| – | – | 0.01% | 280 |
|
|
2025
Q2 | $84.7K | Hold |
174
| – | – | 0.01% | 265 |
|
|
2025
Q1 | $107K | Hold |
174
| – | – | 0.01% | 250 |
|
|
2024
Q4 | $92.2K | Sell |
174
-136
| -44% | -$76.7K | 0.01% | 267 |
|
|
2024
Q3 | $186K | Hold |
310
| – | – | 0.02% | 203 |
|
|
2024
Q2 | $168K | Hold |
310
| – | – | 0.02% | 218 |
|
|
2024
Q1 | $199K | Hold |
310
| – | – | 0.02% | 199 |
|
|
2023
Q4 | $181K | Sell |
310
-13
| -4% | -$7.28K | 0.02% | 204 |
|
|
2023
Q3 | $168K | Hold |
323
| – | – | 0.03% | 189 |
|
|
2023
Q2 | $175K | Hold |
323
| – | – | 0.03% | 191 |
|
|
2023
Q1 | $174K | Hold |
323
| – | – | 0.03% | 189 |
|
|
2022
Q4 | $165K | Sell |
323
-77
| -19% | -$37.5K | 0.03% | 199 |
|
|
2022
Q3 | $175K | Hold |
400
| – | – | 0.03% | 189 |
|
|
2022
Q2 | $188K | Hold |
400
| – | – | 0.03% | 186 |
|
|
2022
Q1 | $203K | Hold |
400
| – | – | 0.03% | 188 |
|
|
2021
Q4 | $212K | Hold |
400
| – | – | 0.04% | 134 |
|
|
2021
Q3 | $186K | Buy |
+400
| New | +$189K | 0.03% | 134 |
|
|
2021
Q1 | $230K | Hold |
500
| – | – | 0.04% | 132 |
|
|
2020
Q4 | $266K | Hold |
500
| – | – | 0.05% | 122 |
|
|
2020
Q3 | $240K | Hold |
500
| – | – | 0.05% | 139 |
|
|
2020
Q2 | $225K | Sell |
500
-33
| -6% | -$14.7K | 0.05% | 145 |
|
|
2020
Q1 | $231K | Hold |
533
| – | – | 0.05% | 137 |
|
|
2019
Q4 | $234K | Hold |
533
| – | – | 0.04% | 160 |
|
|
2019
Q3 | $223K | Hold |
533
| – | – | 0.05% | 149 |
|
|
2019
Q2 | $192K | Sell |
533
-58
| -10% | -$19.4K | 0.04% | 156 |
|
|
2019
Q1 | $189K | Hold |
591
| – | – | 0.04% | 159 |
|
|
2018
Q4 | $167K | Hold |
591
| – | – | 0.04% | 165 |
|
|
2018
Q3 | $189K | Sell |
591
-25
| -4% | -$7.97K | 0.04% | 170 |
|
|
2018
Q2 | $199K | Hold |
616
| – | – | 0.04% | 171 |
|
|
2018
Q1 | $168K | Buy |
616
+9
| +1% | +$2.38K | 0.04% | 178 |
|
|
2017
Q4 | $147K | Hold |
607
| – | – | 0.03% | 168 |
|
|
2017
Q3 | $123K | Sell |
607
-99
| -14% | -$19.5K | 0.03% | 176 |
|
|
2017
Q2 | $145K | Hold |
706
| – | – | 0.04% | 170 |
|
|
2017
Q1 | $129K | Buy |
706
+10
| +1% | +$1.74K | 0.03% | 167 |
|
|
2016
Q4 | $111K | Buy |
696
+71
| +11% | +$10.4K | 0.03% | 161 |
|
|
2016
Q3 | $88K | Hold |
625
| – | – | 0.03% | 175 |
|
|
2016
Q2 | $86K | Hold |
625
| – | – | 0.03% | 197 |
|
|
2016
Q1 | $84K | Hold |
625
| – | – | 0.03% | 198 |
|
|
2015
Q4 | $94K | Hold |
625
| – | – | 0.03% | 204 |
|
|
2015
Q3 | $83K | Hold |
625
| – | – | 0.03% | 203 |
|
|
2015
Q2 | $81K | Sell |
625
-55
| -8% | -$6.8K | 0.02% | 215 |
|
|
2015
Q1 | $81K | Sell |
680
-20
| -3% | -$2.22K | 0.02% | 231 |
|
|
2014
Q4 | $74K | Hold |
700
| – | – | 0.02% | 223 |
|
|
2014
Q3 | $72K | Sell |
700
-130
| -16% | -$13.2K | 0.02% | 219 |
|
|
2014
Q2 | $77K | Hold |
830
| – | – | 0.02% | 220 |
|
|
2014
Q1 | $74K | Hold |
830
| – | – | 0.02% | 212 |
|
|
2013
Q4 | $64K | Buy |
830
+50
| +6% | +$3.69K | 0.02% | 237 |
|
|
2013
Q3 | $56K | Buy |
780
+400
| +105% | +$28.5K | 0.02% | 233 |
|
|
2013
Q2 | $28K | Buy |
+380
| New | +$27.9K | 0.01% | 314 |
|
Other funds holding CHE
Tompkins Financial's CHE Position: Q4 2025 in Review
Tompkins Financial sold out of Chemed (CHE) in Q4 2025, closing a stake of 174 shares — an estimated $77.9K sold.
Tompkins Financial first reported a position in CHE in Q2 2013 and held it in 49 quarters. The position peaked at $266K in Q4 2020. 518 funds tracked by Wall St. Rank hold CHE as of Q4 2025.
- Tompkins Financial reported no remaining Chemed position as of Q4 2025 after selling out during the quarter.
- Tompkins Financial sold 174 Chemed shares in Q4 2025, an estimated $77.9K.
- Tompkins Financial first reported a position in Chemed in Q2 2013 and held it in 49 quarters.
- Tompkins Financial's Chemed position peaked at $266K in Q4 2020.
- 518 funds tracked by Wall St. Rank held Chemed as of Q4 2025.
Based on Tompkins Financial's 13F filing for Q4 2025, filed 8 Jan 2026.